Compare MRI/CT leasing options in Canada—terms, docs lenders want, tax & GST/HST basics, and how underwriters size approvals.
If you’re financing an MRI or CT scanner in Canada, the best path is usually a structured equipment lease that matches (1) the asset’s useful life, (2) your utilization ramp, and (3) your service/upgrade cycle. The “right” deal isn’t just the lowest payment—it’s the deal that keeps your clinic liquid while satisfying lender risk rules: Character, Capacity, Capital, Collateral, and Conditions (the 5Cs).
In practice, most imaging operators end up choosing between:
Below is an “ultimate guide” to MRI & CT scanner financing options in Canada, written from an underwriter’s lens—what lenders actually look for, what breaks approvals, and how to package a file so it funds.
Key point: Lenders finance more than the scanner—if you present it correctly.
When clinics say “MRI/CT purchase,” the real project often includes:
Underwriter note: The more your quote looks like a clean, itemized vendor package—with serializable assets clearly separated from leaseholds—the easier it is to approve and fund.
Key point: There isn’t one “MRI loan.” There are structures—each with tradeoffs.
FMV leases are built for technology that changes, gets software updates, and faces obsolescence risk. You finance the use over a term, then typically:
Why clinics pick FMV for imaging:
MRI/CT platforms evolve, and vendors push upgrade cycles. FMV can keep you from being “stuck” with yesterday’s platform when referrals demand newer protocols.
Watch-outs:
FMV deals can look cheaper monthly, but end-of-term options matter. Know how FMV will be determined and what happens if you want to keep the unit.
If you know you want to own the scanner long-term, a $1 buyout or fixed residual lease is the straightest line. Payments are typically higher than FMV because you’re financing more of the equipment value.
Why clinics pick it:
Stable service lines, predictable utilization, and a long horizon where ownership makes sense.
Underwriter lens:
Ownership structures push the lender to care more about long-term maintenance, resale value, and whether your business can carry the asset if volumes dip.
MRI rooms aren’t “plug and play.” If you have a long lead time (site work → delivery → install → commissioning), you may need:
A progress-funding lease can cover vendor milestones so you don’t drain working capital before the scanner produces revenue.
What lenders will ask: a realistic timeline, milestones, and who’s taking install risk if something slips.
If you already own imaging equipment (or related high-value gear) and want liquidity, a sale-leaseback sells the asset to a finance partner and leases it back to you—converting “metal equity” into cash while you keep operating.
Internal reading (useful context):
Underwriter lens: Documentation must prove clean title and liens, because the lender is buying the asset first, then leasing it back.
Manufacturers sometimes offer promotional rates, deferred payments, or bundles (scanner + service + software). These programs can be excellent—especially when the vendor has strong resale channels.
Contrarian (but practical) take:
The vendor program isn’t always “cheapest.” It can be cheapest on paper but expensive if it locks you into:
Always compare offers apples-to-apples: term, fees, residual/buyout, service requirements, and flexibility.
Key point: A scanner doesn’t get approved—your risk story does.
Most credit teams underwrite using the 5Cs: Character, Capacity, Capital, Collateral, Conditions.
For imaging, capacity is about:
A lender’s mental math: “If volumes are 20–30% lower than forecast for 6–12 months, do they still pay us?”
Capital shows up as:
Yes, the scanner is collateral—but imaging collateral has nuances:
Most lessors register security interests and care deeply about insurability and serviceability.
Imaging is regulated, and capacity can be affected by:
Example (Ontario): Ontario has run processes related to licensing/approvals for community MRI/CT services; if you operate in that environment, lenders may ask how approvals and operating requirements are satisfied. (Ontario)
Key point: If your “base case” doesn’t survive a slow-ramp scenario, the lender will price you higher—or decline you.
Here’s a clean way to stress test the payment:
How underwriters think about this (plain language): They’re trying to reduce the chance of default (probability of default), limit exposure if something happens (exposure at default), and ensure the collateral recovery isn’t a disaster (loss given default).
Key point: MRI/CT terms are driven by useful life + resale + service cycle, not what you “want” monthly.
What tends to move term and pricing:
For a broader rate/quote comparison framework (useful when you’re collecting offers):
https://www.mehmigroup.com/blogs/equipment-lease-rates-canada-2025-guide-tips (Mehmi Financial Group)
Key point: Imaging deals fail more often from missing documentation than from “bad businesses.”
Expect requests like:
Why: Lenders want to verify fundamentals quickly—time in business, credit habits, banking conduct, and the equipment itself.
For clinics specifically, you’ll often get better outcomes if you package the story as “controlled expansion” with a ramp plan (not a hopeful leap). A related guide that’s helpful for that packaging mindset:
https://www.mehmigroup.com/blogs/second-location-equipment-financing-canada-complete-guide (Mehmi Financial Group)
Key point: You can’t evaluate an MRI/CT deal using US advice—timing and tax treatment differ.
CRA’s general guidance explains that you deduct lease payments incurred in the year for property used in your business (subject to the normal rules and specific limitations). (Canada)
If you want a practical walkthrough of how “CCA vs leasing” changes timing (and why timing is the real game):
https://www.mehmigroup.com/blogs/capital-cost-allowance-cca-vs-leasing (Mehmi Financial Group)
CRA publishes common CCA classes and rates, but imaging equipment classification can be fact-specific—especially with bundled software/components. Start with CRA’s CCA classes reference and confirm your exact classification with your tax advisor. (Canada)
A practical “decision guide” version (clinic-friendly):
https://www.mehmigroup.com/blogs/cca-class-for-equipment-canadian-decision-guide-2026 (Mehmi Financial Group)
Most commercial equipment leases charge GST/HST on periodic payments (and many fees). If you’re registered, you can usually claim input tax credits for commercial use (with the usual CRA rules). A Canada-specific explainer:
https://www.mehmigroup.com/blogs/hst-gst-on-equipment-leases-in-canada (Mehmi Financial Group)
Key point: Lenders don’t underwrite policy—but they do underwrite execution risk.
Two common friction points in imaging:
Practical tip: Build a one-page “readiness summary” (site ready date, shielding contractor, power/HVAC, install window, licensing/inspection plan). It speeds up credit and reduces “conditions precedent”—the specific conditions that must be met before funds are advanced.
Key point: Match the structure to your risk, not your optimism.
Choose FMV lease when:
Choose $1 / fixed residual when:
Choose progress funding when:
Consider sale-leaseback when:
If you’re refinancing/reshaping existing equipment payments in a clinic context:
https://www.mehmigroup.com/blogs/medical-equipment-refinancing-canada-clinic-lab-guide (Mehmi Financial Group)
And if you’re trying to understand “capital lease” tax treatment and why some deals are treated as financing:
https://www.mehmigroup.com/blogs/capital-lease-tax-treatment-canada-cca-vs-lease-deductions (Mehmi Financial Group)
Key point: The win wasn’t “cheapest rate.” It was a structure that survived the ramp.
Clinic profile:
The problem:
They could afford the payment once volumes stabilized, but the first 6–9 months would be tight due to:
Underwriter concerns (5Cs):
The structure used (leasing-first):
Outcome:
Why it worked: It treated the ramp as normal (not embarrassing) and built it into the structure—exactly how lenders want to see risk managed.
Key point: Your quote reflects the rate environment and your risk tier.
As of December 10, 2025, the Bank of Canada’s policy interest rate was 2.25%. (Bank of Canada)
That doesn’t translate 1:1 into lease pricing, but it influences funding costs—especially on longer terms.
If you’re evaluating MRI or CT financing and want a structure that fits your ramp and compliance reality—not just the lowest advertised payment—Mehmi Financial Group can help you compare FMV vs $1, model total cost, and package the file so lenders see a controlled, financeable plan.
If you want background reading first, start here:
https://www.mehmigroup.com/blogs/medical-equipment-financing-in-canada (Mehmi Financial Group)
Lease payments are generally deductible when incurred for property used to earn business income, subject to the normal CRA rules and any applicable limitations. (Canada)
Typically yes—GST/HST is charged on periodic lease payments and many fees, based on where the equipment is used. If you’re registered, you can usually claim ITCs for commercial use (with standard CRA rules). See: https://www.mehmigroup.com/blogs/hst-gst-on-equipment-leases-in-canada (Mehmi Financial Group)
Often, yes—especially when those costs are vendor-quoted and directly tied to commissioning the asset. Room buildouts/leaseholds are more lender-dependent and are best itemized separately.
FMV prioritizes flexibility and upgrades (buyout at market value at the end). A $1/fixed residual structure is closer to ownership and typically has higher payments because you’re financing more of the asset value.
There’s no single cutoff. For smaller private clinics, lenders often look at guarantor credit, time in business, bank conduct, and cash flow coverage—then price by risk tier. Packaging and liquidity matter as much as score.
Missing documentation, unclear vendor milestones, and site readiness issues (power/HVAC/shielding/commissioning). A one-page install timeline and an itemized quote often speeds approvals dramatically.
.avif)
.svg){kind=small}